Keng Kiat Toh
CIK: 0001973295
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GDTC
CytoMed Therapeutics Ltd
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Toh Keng Kiat
Toh Keng Kiat (SEC CIK 0001973295) files insider reports with the SEC as Director of CytoMed Therapeutics Ltd (GDTC).
Signal8 holds 1 ownership filing by Toh Keng Kiat, a Form 3, filed on May 26, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Toh Keng Kiat's filings is in SINGAPORE.
Other insiders filing for CytoMed Therapeutics Ltd (GDTC)
- Choo Chee Kong, Director
- Yew Chak Hua, Director
- Leong Mark Kei Wei, Director
- TAN YOONG YING, Chief Corporate Officer
- Goh Yvonne, Chief Financial Officer